An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression.
about
Unexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesisNovel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewTargeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphomac-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells.TRAF3: a novel tumor suppressor gene in macrophages.The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development.Nuclear TRAF3 is a negative regulator of CREB in B cells.Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell developmentSynergistic activity of Card11 mutant and Bcl6 in the development of diffuse large B-cell lymphoma in a mouse model.Double-hit lymphomas: clinical, morphological, immunohistochemical and cytogenetic study in a series of Brazilian patients with high-grade non-Hodgkin lymphomaSmall Molecule Inhibition of Rab7 Impairs B Cell Class Switching and Plasma Cell Survival To Dampen the Autoantibody Response in Murine Lupus.Murine models of germinal center derived-lymphomas.Physiological and Pathological Transcriptional Activation of Endogenous Retroelements Assessed by RNA-Sequencing of B Lymphocytes.Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses.Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.NF-κB in Hematological Malignancies.NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy.Genetic Alterations of TRAF Proteins in Human CancersTRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation
P2860
Q26822486-B31526B5-5C47-45AE-9265-578A9D67CBEAQ27304386-1BC47E2A-55C2-4939-A38B-2D70F899C625Q28115962-323218D6-70FF-4C3F-B9F1-C02FD6BB08D4Q33815997-A41ED10C-B0F8-4508-8CFC-546084784900Q36357661-1231A603-AD31-417C-A511-CC97CE2C0B1FQ36485370-39BB1E6C-540B-4EF0-BEB3-46F8749B89EFQ36551524-ECAD49A9-126D-4022-B46E-8688688F852DQ37181833-1E92F780-9130-4EA3-99B1-AE125F1E10CCQ37462631-5C4EB4C0-E08F-4D4A-93CE-C950E81F84D3Q37569804-4AA6A553-276E-4E84-A2B5-08A3F78FA4F6Q37835582-1F1AC6BE-0B4F-4416-855A-290ED5B09C5EQ39119409-AF576B3B-1BC6-4FCC-8355-4CD5445E4C4CQ47194262-D9FBCFE7-449A-460A-BAB2-6C53C380997BQ47195330-F7A07A0B-39F1-4AD6-9686-D154FCAB6E89Q51075776-C1EBEA58-672E-4EBF-BA85-6EE0FD458C6AQ54147337-ABCC97CA-D1F9-4AA0-970D-875528338CE1Q54247368-0D96CAAF-D829-4B0A-978A-66D04782D547Q57191736-4A98CF74-45FF-4B4A-ADA5-A28A8A62E757Q57492396-D8926FD1-2765-4D59-9554-C322282A1529
P2860
An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
An oncogenic role for alternat ...... n deregulated BCL6 expression.
@ast
An oncogenic role for alternat ...... n deregulated BCL6 expression.
@en
type
label
An oncogenic role for alternat ...... n deregulated BCL6 expression.
@ast
An oncogenic role for alternat ...... n deregulated BCL6 expression.
@en
prefLabel
An oncogenic role for alternat ...... n deregulated BCL6 expression.
@ast
An oncogenic role for alternat ...... n deregulated BCL6 expression.
@en
P2093
P2860
P50
P1433
P1476
An oncogenic role for alternat ...... n deregulated BCL6 expression.
@en
P2093
Christine Unitt
Dinis Pedro Calado
Frederick W Alt
Marc Schmidt-Supprian
Riccardo Dalla-Favera
Scott Rodig
Sergei B Koralov
Yoshiteru Sasaki
P2860
P304
P356
10.1016/J.CELREP.2015.03.059
P577
2015-04-23T00:00:00Z